Accuray Incorporated (LON:0H8I)

Market Cap	89.95M
Revenue (ttm)	335.44M
Net Income (ttm)	-14.37M
Shares Out	n/a
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,121
Average Volume	11,520
Open	1.100
Previous Close	1.110
Day's Range	1.068 - 1.100
52-Week Range	0.923 - 2.940
Beta	n/a
RSI	44.90
Earnings Date	Jan 28, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1990
• Employees: 990
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD